Hjem › Burkitts lymfom › Michigan › Grand Rapids
Kliniske studier for Burkitts lymfom i Grand Rapids, MI
7 studier for Burkitts lymfom søker deltakere på steder i og rundt Grand Rapids (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RekruttererFase 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Corewell Health ( Site 1001), Grand Rapids
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
RekruttererFase 2
- Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids
Burkitts lymfom-studier i andre byer
- Houston, TX21 studier
- Philadelphia, PA16 studier
- Milwaukee, WI16 studier
- Chicago, IL15 studier
- Cincinnati, OH13 studier
- New York City, NY13 studier
- Atlanta, GA12 studier
- Aurora, CO11 studier
- Seattle, WA11 studier
- Durham, NC10 studier
- Boston, MA10 studier
- Kansas City, MO10 studier
Andre studier i Grand Rapids
- Ikke-småcellet lungekreft44 studier
- Kolorektal kreft40 studier
- Kreft (alle typer)28 studier
- Brystkreft26 studier
- Eggstokkreft24 studier
- Metastatisk kreft22 studier
- Prostatakreft19 studier
- Endometriekreft18 studier
- Mavekreft18 studier
- Pankreaskreft18 studier
- Melanom17 studier
- Plateepitelcancer i hode og hals15 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.